A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis
Clinical trial NCT06035354 · COMPLETED
Trial details
- NCT number
- NCT06035354
- Sponsor
- Akeso
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-03
- Primary completion
- 2024-06-21
- Enrollment
- 427
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.